SHIM
INSM icon

Stone House Investment Management’s Insmed INSM Stock Holding History

Stone House Investment Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$53.4K Buy
501
+301
+151% +$36.4K 0.01% 210
2026
Q1 		$32.7K Sell
200
-2
-1% -$307 0.01% 226
2025
Q4 		$35.2K Buy
202
+2
+1% +$365 0.01% 199
2025
Q3 		$28.8K Buy
+200
New +$24.5K ﹤0.01% 196

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Stone House Investment Management's INSM Position: Q2 2026 in Review

Stone House Investment Management increased its Insmed (INSM) stake by 151% in Q2 2026, buying an estimated $36.4K and bringing the position to 501 shares worth $53.4K. The position accounts for 0.01% of the portfolio, ranked #210.

Stone House Investment Management first reported a position in INSM in Q3 2025 and has held it in 4 quarters since. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Stone House Investment Management held 501 shares of Insmed worth $53.4K as of Q2 2026.
  • Stone House Investment Management bought 301 Insmed shares in Q2 2026, an estimated $36.4K.
  • Insmed made up 0.01% of Stone House Investment Management's portfolio in Q2 2026, its #210 holding.
  • Stone House Investment Management first reported a position in Insmed in Q3 2025 and has held it in 4 quarters since.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Stone House Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.